WO2011068438A2 - Средство для лечения и профилактики заболеваний мочеполовой системы мужчин - Google Patents
Средство для лечения и профилактики заболеваний мочеполовой системы мужчин Download PDFInfo
- Publication number
- WO2011068438A2 WO2011068438A2 PCT/RU2010/000703 RU2010000703W WO2011068438A2 WO 2011068438 A2 WO2011068438 A2 WO 2011068438A2 RU 2010000703 W RU2010000703 W RU 2010000703W WO 2011068438 A2 WO2011068438 A2 WO 2011068438A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- diseases
- licorice
- prevention
- agent
- Prior art date
Links
- 210000002229 urogenital system Anatomy 0.000 title claims abstract description 9
- 230000006806 disease prevention Effects 0.000 title claims abstract description 6
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 29
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 29
- 244000144987 brood Species 0.000 claims abstract description 14
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 10
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 10
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 3
- 239000012675 alcoholic extract Substances 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 8
- 239000003795 chemical substances by application Substances 0.000 abstract description 5
- 210000004907 gland Anatomy 0.000 abstract description 4
- 230000027939 micturition Effects 0.000 abstract description 4
- 230000036299 sexual function Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 230000001760 anti-analgesic effect Effects 0.000 abstract 1
- 210000004995 male reproductive system Anatomy 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 19
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 19
- 229940010454 licorice Drugs 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 229940088597 hormone Drugs 0.000 description 7
- 239000005556 hormone Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 210000002307 prostate Anatomy 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000003054 hormonal effect Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 206010036940 Prostatic adenoma Diseases 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000001363 autoimmune Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229930195247 licorice glycoside Natural products 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- -1 anti-acid Substances 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000030214 innervation Effects 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 230000002475 laxative effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 210000004994 reproductive system Anatomy 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- GTEBNRQRSIJPHQ-XFFWNHRZSA-N (2s,4ar,6ar,6as,6br,8ar,10s,12as)-10-hydroxy-2,6a,6b,9,9,12a-hexamethyl-13-oxo-3,4,4a,5,6,6a,7,8,8a,10,11,12-dodecahydropicene-2-carboxylic acid Chemical compound O=C([C@H]12)C=C3C4=C[C@@](C)(C(O)=O)CC[C@H]4CC[C@@]3(C)[C@]2(C)CC[C@@H]2[C@]1(C)CC[C@H](O)C2(C)C GTEBNRQRSIJPHQ-XFFWNHRZSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000032420 Latent Infection Diseases 0.000 description 1
- 208000030289 Lymphoproliferative disease Diseases 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002930 anti-sclerotic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 235000019788 craving Nutrition 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000008995 mustong Substances 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 210000005267 prostate cell Anatomy 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229940083492 sitosterols Drugs 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
Definitions
- the invention relates to the pharmaceutical industry, producing medicines, and can be used to prevent diseases of the genitourinary system in men.
- the licorice root rejuvenates the body (Mustong phytodrugs from Orient Pharma Priveit, Enhance from Enrich, USA), is used for weight loss (Nova figure phytodrugs from Naturvaren, Germany), treatment digestive organs (herbal preparations "Tiem Long”, “Thang Long” company “Bao Long”, Vietnam).
- the closest analogue to the claimed tool is a therapeutic and prophylactic agent for the treatment of diseases of the genitourinary sphere, containing in its composition the licorice root bare (RU 20981 19 C1, 12/10/1997).
- the disadvantage of the closest analogue is the multicomponent nature, and, as a result, individual intolerance of the individual components observed in individuals. In addition, it should be noted low therapeutic activity.
- the objective of the invention is to develop a convenient form of administration, expanding the range of products for the prevention and treatment of diseases of the genitourinary sphere in men with a wide therapeutic effect.
- the technical result consists in the stimulation of the glands and the normalization of the reproductive system of men, the manifestation of anti-inflammatory, analgesic, normalizing urination and restoring sexual function.
- drone brood As a donor of sex entomological hormones: prolactin, estradiol, progesterone, testosterone - which have a stimulating effect on the reproductive functions of men. Saturated with vitamins and hormones that are not hormone substitutes, drone brood is effective for hormonal disorders.
- the claimed tool for the treatment and prevention of diseases of the genitourinary system of men is a finely divided powder and can be made in the form of tablets or capsules or an aqueous-alcoholic extract.
- the components that make up the claimed drug are known in traditional and traditional medicine, their combination in one product is not known from the prior art, namely, the discovered synergistic effect allowed us to solve the problem and achieve the claimed technical result, namely, to enhance the therapeutic effect in the treatment diseases of the genitourinary sphere in men.
- Example 1 Dried and ground (the technology is protected by RF patent N ° 2342943) the roots of licorice are mixed with drone brood in a ratio by weight of 75% and 25%, respectively.
- the powder thus obtained has a light beige color, a sugary-sweet taste, an uncharacteristic smell.
- Example 2 Dried and crushed (the technology is protected by RF patent N ° 2342943) the roots of licorice are mixed with drone brood in a ratio by weight of 50%, respectively.
- the powder thus obtained has a light beige color, a sugary-sweet taste, an uncharacteristic smell.
- the obtained product is an effective alternative to decoctions and tinctures, since in a properly dried and finely ground powder, the fragile membrane of cells breaks down and healing substances in their full wealth and with maximum preservation of activity turn into powder, which can then be used as an independent product in the form of tablets, capsules or water-alcohol extract.
- the active substances of all the above forms of a therapeutic and prophylactic agent based on the roots of licorice and drone brood are, in particular, tannins, flavonoids, organic acids, terpenoids, heterocyclic compounds, higher aliphatic hydrocarbons, triterpinoids, steroids, lignin, coumarins, alcohols, higher fatty acid, glycosides, vitamins, minerals, trace elements, entomological hormones, amino acids, enzymes.
- the expediency of the combined use of the listed components is confirmed by the fact that when the combination of the use of plant and animal products is used, an increase in the pharmacological activity of the components is observed.
- the action of the constituent substances of licorice and drone brood occurs in different ways. Licorice primarily works due to glycosides. The structure of licorice glycosides is similar to the structure of hormones secreted by the adrenal glands. Licorice glycosides have anti-inflammatory, moderately antibacterial, and immunomodulating effects, strengthen capillaries, regulate metabolism. Licorice beta-sitosterols prevent the development of prostate adenoma, enhance urination.
- licorice - beta-glycyrrhizic acid - acts in many ways like corticosteroid hormones, which are associated with pronounced anti-inflammatory and anti-allergic properties of licorice.
- Licorice components have powerful antioxidant properties and also help to effectively lower blood cholesterol.
- Drone brood acts due to enzymes, amino acids, a complex of vitamins, macro and microelements, hormones and growth factors that stimulate cell metabolism. T.O. the complexity and versatility of the effect on the human body is achieved, both on the disease itself (consequence), and on the causes of its appearance.
- Difficulties in the treatment of prostate dysfunction are determined by a variety of etiological factors causing pathological changes on the part of the prostate and organs integrated with it into the general blood supply and innervation system.
- the most significant etiological factor is a violation of mncirculation in the prostate (licorice glycosides are used for treatment), which leads to a change in biochemical and bactericidal properties of the secret, autoimmune reactions, lowering the barrier function of the prostate, which becomes a prerequisite for both the penetration of infection and the aggravation of the course of inflammation.
- Drone brood prevents pathological changes in the prostate: reduces the activity of inflammatory and autoimmune processes in the tissues of the prostate, prevents the conversion of testosterone to dihydrotestosterone and controls the excessive reproduction of prostate cells.
- the complex of active active ingredients of the claimed means stimulates the glands and normalizes the reproductive system of men, has anti-inflammatory, analgesic, normalizing urination and restores sexual function.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Insects & Arthropods (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL10834824T PL2508192T3 (pl) | 2009-12-02 | 2010-11-25 | Środek do leczenia i profilaktyki chorób męskiego układu moczowo-płciowego |
UAA201208114A UA110200C2 (en) | 2009-12-02 | 2010-11-25 | Agent for treatment and prevention of men genitourinary system disease |
RS20140503A RS53534B1 (en) | 2009-12-02 | 2010-11-25 | AGENCY FOR TREATMENT AND PREVENTION OF MEN'S UROGENITAL DISEASE |
EA201200895A EA021315B1 (ru) | 2009-12-02 | 2010-11-25 | Средство для лечения и профилактики заболеваний мочеполовой системы мужчин |
DK10834824.4T DK2508192T3 (da) | 2009-12-02 | 2010-11-25 | Middel til anvendelse i behandling og forebyggelse af sygdomme i det mandlige urogenitale system |
EP10834824.4A EP2508192B1 (en) | 2009-12-02 | 2010-11-25 | Agent for the treatment and prevention of diseases of the male urogenital system |
SI201030749T SI2508192T1 (sl) | 2009-12-02 | 2010-11-25 | Sredstvo za zdravljenje in preprečevanje bolezni moškega urogenitalnega sistema |
ES10834824.4T ES2507141T3 (es) | 2009-12-02 | 2010-11-25 | Agente para el tratamiento y la prevención de enfermedades del sistema urogenital masculino |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009144836 | 2009-12-02 | ||
RU2009144836/15A RU2423142C1 (ru) | 2009-12-02 | 2009-12-02 | Средство для лечения и профилактики заболеваний мочеполовой системы мужчин |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011068438A2 true WO2011068438A2 (ru) | 2011-06-09 |
WO2011068438A3 WO2011068438A3 (ru) | 2011-07-28 |
Family
ID=44115447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU2010/000703 WO2011068438A2 (ru) | 2009-12-02 | 2010-11-25 | Средство для лечения и профилактики заболеваний мочеполовой системы мужчин |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2508192B1 (ru) |
DK (1) | DK2508192T3 (ru) |
EA (1) | EA021315B1 (ru) |
ES (1) | ES2507141T3 (ru) |
PL (1) | PL2508192T3 (ru) |
PT (1) | PT2508192E (ru) |
RS (1) | RS53534B1 (ru) |
RU (1) | RU2423142C1 (ru) |
SI (1) | SI2508192T1 (ru) |
UA (1) | UA110200C2 (ru) |
WO (1) | WO2011068438A2 (ru) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2756848A1 (en) * | 2011-09-16 | 2014-07-23 | Obshestvo S Ogranichennoj Otvetstvennostju "PARAFARM" | Method for preparing an adsorbed drone brood and the composition thereof |
EP2886114A4 (en) * | 2012-08-20 | 2016-03-30 | Obshestvo S Ogranichennoj Otvetstvennostju Parafarm | METHOD FOR RESTORING SEXUAL ATTRACTION IN MAN (LIBIDO) BY ABSORPTION OF BIOACTIVE ADDITIVES IN FOOD |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2425593C1 (ru) * | 2010-05-04 | 2011-08-10 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище для нормализации уровня андрогенов мужчин, общего состояния, снижения ожирения |
Citations (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1697820A1 (ru) | 1985-09-10 | 1991-12-15 | 1-Й Московский Медицинский Институт Им.И.М.Сеченова | Средство дл лечени сахарного диабета |
RU1826910C (ru) | 1991-05-12 | 1993-07-07 | В.А.Чуйко и Г.Н.Спиридонова | Биостимулирующее средство |
SU1836094A3 (en) | 1992-01-16 | 1993-08-23 | Чуйko Bлaдиmиp Ahatoльebич | Remedy for restoration and stimulation of the endocrine and immune systems |
RU2000799C1 (ru) | 1992-09-24 | 1993-10-15 | Малое предпри тие "Европа" | Стимул тор иммунологической резистентности организма |
RU2000806C1 (ru) | 1992-10-13 | 1993-10-15 | Пономарева Анна Геннадиевна Поверин Дмитрий Иванович | "Сбор дл лечени гастритов с повышенной кислотностью, звенной болезни желудка и двенадцатиперстной кишки "Дмитрий"" |
RU2003340C1 (ru) | 1989-01-04 | 1993-11-30 | Институт клинической иммунологии СО РАМН | Иммунодепрессант |
RU2008914C1 (ru) | 1992-09-28 | 1994-03-15 | Макеев Борис Александрович | Бальзам, обладающий адаптогенным действием |
RU2013094C1 (ru) | 1990-12-17 | 1994-05-30 | Рязанский медицинский институт им.акад.И.П.Павлова | Сбор лекарственных трав для лечения хронического бронхита |
RU2020952C1 (ru) | 1993-04-01 | 1994-10-15 | Анна Генадиевна Пономарева | Сбор лекарственных растений "глая", "дарья", "елена", "ева", обладающий общеукрепляющим и антисклеротическим действием |
RU2020950C1 (ru) | 1993-04-01 | 1994-10-15 | Анна Генадиевна Пономарева | Сбор лекарственных растений "вера" для реабилитации организма после орз |
RU2027438C1 (ru) | 1992-02-07 | 1995-01-27 | Степанова Элеонора Федоровна | Способ получения средства, обладающего антианафилактическим действием |
RU2032420C1 (ru) | 1993-10-27 | 1995-04-10 | Лидия Федоровна Охременко | Лекарственный сбор для детоксикации организма (варианты) и способ детоксикации организма |
RU2034558C1 (ru) | 1993-07-01 | 1995-05-10 | Дамбинова Светлана Александровна | Вещество, обладающее радиозащитной активностью, и способ его получения |
RU2044547C1 (ru) | 1993-11-18 | 1995-09-27 | Леонид Петрович Бурага | Средство для профилактики и лечения злокачественных новообразований |
RU2045955C1 (ru) | 1992-02-24 | 1995-10-20 | Никитина Татьяна Ивановна | Способ лечения аднекситов |
RU2063764C1 (ru) | 1994-02-08 | 1996-07-20 | Николай Николаевич Бобров-Егоров | Биологически-активная композиция "фитаон-2" и способ ее получения |
RU2072862C1 (ru) | 1993-01-18 | 1997-02-10 | Александр Иванович Суханов | Легочный сбор |
RU2082426C1 (ru) | 1995-06-07 | 1997-06-27 | Наталья Валентиновна Зеневич | Способ получения средства для лечения псориаза "апсорин" и способ лечения псориаза |
RU2087154C1 (ru) | 1994-08-16 | 1997-08-20 | Ессентукский центральный военный санаторий | Способ получения средства для лечения хронического холецистита, обладающего желчегонным и гепатозащитным действием |
RU2088249C1 (ru) | 1994-04-18 | 1997-08-27 | Научно-исследовательский институт фармакологии Томского научного центра РАМН | Гемостимулятор |
RU2088252C1 (ru) | 1994-09-26 | 1997-08-27 | Василий Николаевич Дармограй | Лекарственный сбор для лечения и профилактики цистита |
RU2097052C1 (ru) | 1994-09-26 | 1997-11-27 | Анна Геннадьевна Пономарева | Лекарственный сбор для очищения организма |
RU2097053C1 (ru) | 1994-09-26 | 1997-11-27 | Анна Геннадьевна Пономарева | Лекарственный сбор "петрович" для снятия тяги к алкоголю |
RU2098119C1 (ru) | 1996-05-21 | 1997-12-10 | Научно-производственное объединение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений" | Лечебно-профилактическое средство "простанорм" для лечения простатитов, уретритов и других воспалительных заболеваний мочеполовой сферы |
RU2103002C1 (ru) | 1996-12-25 | 1998-01-27 | Красногорское акционерное общество открытого типа "Лекарственные средства" | Сбор грудной |
RU2103001C1 (ru) | 1996-12-25 | 1998-01-27 | Красногорское акционерное общество открытого типа "Лекарственные средства" (АО "Красногорсклексредства") | Сбор желудочно-кишечный |
RU2191525C2 (ru) | 2000-09-29 | 2002-10-27 | Закрытое акционерное общество "Эвалар" | Биологически активная добавка к пище для профилактики расстройств мочеполовой системы |
RU2342943C2 (ru) | 2006-12-15 | 2009-01-10 | Общество С Ограниченной Ответственностью "Парафарм" | Лекарственное средство |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RO104981B1 (ro) * | 1989-09-19 | 1994-09-30 | Produse Cosmetice Miraj De | Prodos antireomatfc |
RU2225213C2 (ru) * | 2002-03-04 | 2004-03-10 | Пятигорская государственная фармацевтическая академия | Суппозитории "апипрост", обладающие ранозаживляющим действием |
-
2009
- 2009-12-02 RU RU2009144836/15A patent/RU2423142C1/ru active
-
2010
- 2010-11-25 DK DK10834824.4T patent/DK2508192T3/da active
- 2010-11-25 UA UAA201208114A patent/UA110200C2/ru unknown
- 2010-11-25 SI SI201030749T patent/SI2508192T1/sl unknown
- 2010-11-25 EA EA201200895A patent/EA021315B1/ru unknown
- 2010-11-25 RS RS20140503A patent/RS53534B1/en unknown
- 2010-11-25 WO PCT/RU2010/000703 patent/WO2011068438A2/ru active Application Filing
- 2010-11-25 EP EP10834824.4A patent/EP2508192B1/en active Active
- 2010-11-25 PT PT108348244T patent/PT2508192E/pt unknown
- 2010-11-25 ES ES10834824.4T patent/ES2507141T3/es active Active
- 2010-11-25 PL PL10834824T patent/PL2508192T3/pl unknown
Patent Citations (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1697820A1 (ru) | 1985-09-10 | 1991-12-15 | 1-Й Московский Медицинский Институт Им.И.М.Сеченова | Средство дл лечени сахарного диабета |
RU2003340C1 (ru) | 1989-01-04 | 1993-11-30 | Институт клинической иммунологии СО РАМН | Иммунодепрессант |
RU2013094C1 (ru) | 1990-12-17 | 1994-05-30 | Рязанский медицинский институт им.акад.И.П.Павлова | Сбор лекарственных трав для лечения хронического бронхита |
RU1826910C (ru) | 1991-05-12 | 1993-07-07 | В.А.Чуйко и Г.Н.Спиридонова | Биостимулирующее средство |
SU1836094A3 (en) | 1992-01-16 | 1993-08-23 | Чуйko Bлaдиmиp Ahatoльebич | Remedy for restoration and stimulation of the endocrine and immune systems |
RU2027438C1 (ru) | 1992-02-07 | 1995-01-27 | Степанова Элеонора Федоровна | Способ получения средства, обладающего антианафилактическим действием |
RU2045955C1 (ru) | 1992-02-24 | 1995-10-20 | Никитина Татьяна Ивановна | Способ лечения аднекситов |
RU2000799C1 (ru) | 1992-09-24 | 1993-10-15 | Малое предпри тие "Европа" | Стимул тор иммунологической резистентности организма |
RU2008914C1 (ru) | 1992-09-28 | 1994-03-15 | Макеев Борис Александрович | Бальзам, обладающий адаптогенным действием |
RU2000806C1 (ru) | 1992-10-13 | 1993-10-15 | Пономарева Анна Геннадиевна Поверин Дмитрий Иванович | "Сбор дл лечени гастритов с повышенной кислотностью, звенной болезни желудка и двенадцатиперстной кишки "Дмитрий"" |
RU2072862C1 (ru) | 1993-01-18 | 1997-02-10 | Александр Иванович Суханов | Легочный сбор |
RU2020952C1 (ru) | 1993-04-01 | 1994-10-15 | Анна Генадиевна Пономарева | Сбор лекарственных растений "глая", "дарья", "елена", "ева", обладающий общеукрепляющим и антисклеротическим действием |
RU2020950C1 (ru) | 1993-04-01 | 1994-10-15 | Анна Генадиевна Пономарева | Сбор лекарственных растений "вера" для реабилитации организма после орз |
RU2034558C1 (ru) | 1993-07-01 | 1995-05-10 | Дамбинова Светлана Александровна | Вещество, обладающее радиозащитной активностью, и способ его получения |
RU2032420C1 (ru) | 1993-10-27 | 1995-04-10 | Лидия Федоровна Охременко | Лекарственный сбор для детоксикации организма (варианты) и способ детоксикации организма |
RU2044547C1 (ru) | 1993-11-18 | 1995-09-27 | Леонид Петрович Бурага | Средство для профилактики и лечения злокачественных новообразований |
RU2063764C1 (ru) | 1994-02-08 | 1996-07-20 | Николай Николаевич Бобров-Егоров | Биологически-активная композиция "фитаон-2" и способ ее получения |
RU2088249C1 (ru) | 1994-04-18 | 1997-08-27 | Научно-исследовательский институт фармакологии Томского научного центра РАМН | Гемостимулятор |
RU2087154C1 (ru) | 1994-08-16 | 1997-08-20 | Ессентукский центральный военный санаторий | Способ получения средства для лечения хронического холецистита, обладающего желчегонным и гепатозащитным действием |
RU2097053C1 (ru) | 1994-09-26 | 1997-11-27 | Анна Геннадьевна Пономарева | Лекарственный сбор "петрович" для снятия тяги к алкоголю |
RU2088252C1 (ru) | 1994-09-26 | 1997-08-27 | Василий Николаевич Дармограй | Лекарственный сбор для лечения и профилактики цистита |
RU2097052C1 (ru) | 1994-09-26 | 1997-11-27 | Анна Геннадьевна Пономарева | Лекарственный сбор для очищения организма |
RU2082426C1 (ru) | 1995-06-07 | 1997-06-27 | Наталья Валентиновна Зеневич | Способ получения средства для лечения псориаза "апсорин" и способ лечения псориаза |
RU2098119C1 (ru) | 1996-05-21 | 1997-12-10 | Научно-производственное объединение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений" | Лечебно-профилактическое средство "простанорм" для лечения простатитов, уретритов и других воспалительных заболеваний мочеполовой сферы |
RU2103002C1 (ru) | 1996-12-25 | 1998-01-27 | Красногорское акционерное общество открытого типа "Лекарственные средства" | Сбор грудной |
RU2103001C1 (ru) | 1996-12-25 | 1998-01-27 | Красногорское акционерное общество открытого типа "Лекарственные средства" (АО "Красногорсклексредства") | Сбор желудочно-кишечный |
RU2191525C2 (ru) | 2000-09-29 | 2002-10-27 | Закрытое акционерное общество "Эвалар" | Биологически активная добавка к пище для профилактики расстройств мочеполовой системы |
RU2342943C2 (ru) | 2006-12-15 | 2009-01-10 | Общество С Ограниченной Ответственностью "Парафарм" | Лекарственное средство |
Non-Patent Citations (2)
Title |
---|
MOGILNY N.P.: "Herbal, Moscow", 1997, VSV-SPHINX |
PASHINSKY V.T.: "Plants in the Therapy and Prevention of Diseases", 1989, TOMSK UNIVERSITY PUBLISHERS |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2756848A1 (en) * | 2011-09-16 | 2014-07-23 | Obshestvo S Ogranichennoj Otvetstvennostju "PARAFARM" | Method for preparing an adsorbed drone brood and the composition thereof |
EP2756848A4 (en) * | 2011-09-16 | 2014-12-17 | Obshestvo S Ogranichennoj Otvetstvennostju Parafarm | METHOD FOR PRODUCING AN ADSORBED DRIP BROTH AND COMPOSITION THEREOF |
EP2886114A4 (en) * | 2012-08-20 | 2016-03-30 | Obshestvo S Ogranichennoj Otvetstvennostju Parafarm | METHOD FOR RESTORING SEXUAL ATTRACTION IN MAN (LIBIDO) BY ABSORPTION OF BIOACTIVE ADDITIVES IN FOOD |
EP3750532A1 (en) * | 2012-08-20 | 2020-12-16 | Obshestvo S Ogranichennoj Otvetstvennostju "PARAFARM" | A food supplement for use in restoring male sex drive (libido) |
Also Published As
Publication number | Publication date |
---|---|
DK2508192T3 (da) | 2014-09-29 |
PT2508192E (pt) | 2014-09-24 |
UA110200C2 (en) | 2015-12-10 |
EA201200895A1 (ru) | 2013-03-29 |
EA021315B1 (ru) | 2015-05-29 |
EP2508192B1 (en) | 2014-07-09 |
ES2507141T3 (es) | 2014-10-14 |
PL2508192T3 (pl) | 2014-12-31 |
RU2423142C1 (ru) | 2011-07-10 |
WO2011068438A3 (ru) | 2011-07-28 |
RS53534B1 (en) | 2015-02-27 |
SI2508192T1 (sl) | 2014-11-28 |
EP2508192A2 (en) | 2012-10-10 |
EP2508192A4 (en) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20100022539A (ko) | 발기부전(勃起不全)증 및 혈액순환(血液循環) 개선제조성물 | |
Solanki | Treatment of skin diseases through medicinal plants in different regions of the world | |
CN103041042B (zh) | 一种藏药组合物及其在防脱生发产品中的应用 | |
CN109316528A (zh) | 一种治疗男性勃起功能障碍的药物及其制备方法 | |
CN105708970B (zh) | 一种具有降血糖功能的保健食品 | |
RU2423142C1 (ru) | Средство для лечения и профилактики заболеваний мочеполовой системы мужчин | |
CN105287837A (zh) | 一种用于治疗痔疮的中药复方制剂及其制备方法 | |
RU2178660C2 (ru) | Лечебно-оздоровительная биологически активная добавка к пище "милона" и способ ее получения | |
CN100387291C (zh) | 一种治疗肺结核的药物 | |
KR100522176B1 (ko) | 남성 성기능 개선 조성물 | |
CN101816708B (zh) | 治疗风湿病的中药组合物及其制备方法 | |
KR101540107B1 (ko) | 반복적 희석 및 진탕을 이용한 경구용 제제의 제조방법 | |
RU2191525C2 (ru) | Биологически активная добавка к пище для профилактики расстройств мочеполовой системы | |
CN104352610A (zh) | 一种秘方接骨药膏贴及其制备方法 | |
CN101352924B (zh) | 治疗接骨的中药及制作方法 | |
Mustafa et al. | Ethnobotanical and pharmacological importance of the herbal plants with anti-hair fall and hair growth activities | |
CN103520475B (zh) | 一种用于治疗皮肤瘙痒的药物组合物 | |
Raveena et al. | Evaluation of Ethanol Extract of Caesalpinia bonducella L. Seeds on Hyperthyrodism | |
CN112402565B (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
Awang | Gotu kola | |
WO2002094297A1 (en) | Herbal composition for the treatment of drug addiction and insomnia | |
RU2259205C1 (ru) | Лечебно-профилактическое средство при заболеванях мочеполовой системы у мужчин | |
CN112439016A (zh) | 一种治疗急性软组织损伤的中药组合物、制备方法及应用 | |
Simons | The Healing Power of Plants: Medical Plants from Abuta and Acerola to Yohimbe and Yucca: a Practical Selection | |
RU2171683C1 (ru) | Средство для лечения псориаза (варианты) и способ его лечения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10834824 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: A201208114 Country of ref document: UA Ref document number: 2010834824 Country of ref document: EP Ref document number: 201200895 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: P-2014/0503 Country of ref document: RS |